Translate this page into:
Incidence and Pattern of Bacterial Growth in Propofol Vial - An In vitro Study
Corresponding Author: Rashmi Soorik, C-001, KSHEMA Staff quarters, Deralakatte, Mangalore Mangalore, Mobile: +91 80501 52374, E-mail: drrashmisoori@gmail.com
-
Received: ,
Accepted: ,
This article was originally published by Thieme Medical and Scientific Publishers Private Ltd. and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Introduction
Propofol vials are often used in parts or are opened and left unattended. This has lead to blood stream infections, surgical site infections and acute febrile episodes. A prospective observational study was undertaken to know the incidence and pattern of bacterial growth in samples of Propofol in tropical climate.
Materials and methods
Samples were collected from vials of propofol of different brands, both with and without edetate at different time intervals with relation to room temperature. Each sample of 1ml were inoculated in Brain Heart Infusion (BHI) and incubated for 48hours. Presence of bacterial growth and their pattern were studied.
Statistical analysis used
Paired t test for categorical variables and for non categorical variables Levine’s test and Pearson correlation. Results- Overall 42.26% of samples showed bacterial growth. The incidence was more in samples of propofol without edetate (43.75%) compared to samples with edetate (41.97 %). Most common organism was Staphylococcus aureus, followed by Enterococcus, Acinetobacter, Bacillus species, Pseudomonas and Staphylococcus citrus.
Conclusion
Propofol vial once opened favours bacterial colonisation and growth. Adding edetate to propofol has not shown much benefit in decreasing the incidence.
Keywords
Propofol
Contamination
Bacterial growth
Introduction
Propofol, being a lipid emulsion, is a good medium for bacterial growth. Adhering to manufacturer's recommendations of “use without delay” is often difficult. This is because of the need to use small quantity of the drug during general anaesthesia, such as to reduce the intubation response, increase the depth of anaesthesia, prevention of extubation response and laryngospasm in addition to induction of anaesthesia. This results in a delay between opening of the vial and using the last portion of the drug. Extrinsic contamination of propofol by various microorganisms has been associated with outbreaks of bloodstream infections, surgical site infections, and acute febrile episodes1, 2, 3, 4
Available literature regarding bacterial growth in propofol as such and effect of additives such as edetate is scanty. Further, the pattern of bacteria also depends on the geographic location and temperature. Hence, a study was undertaken to find out the pattern of bacterial growth in a series of randomly selected samples of propofol.
Materials and methods
A prospective observational study was conducted in department of Anaesthesiology in association with department of Microbiology in a tertiary care hospital. The study was conducted with the aim to determine the incidence of growth of microorganisms in samples of propofol in tropical climate, the pattern of microbial growth and any difference in incidence between samples of propofol with or without edetate. The study sample was collected from different operation theatres. Vials of propofol, both with and without edetate were used for the study. The opening time of all the vials, from which samples were obtained, was noted. Subsequently, series of samples were taken at different intervals starting from immediately after opening the vial to as long as 6hrs 30minutes. The samples were collected using 2cc syringe with aseptic precautions. Each sample of 1ml was inoculated in Brain Heart Infusion (BHI) in cork screw bottles and the theatre temperature was noted. The cork screw bottles were transported to microbiology laboratory. The incubation in the microbiology department was performed within 30 minutes of inoculation in the transport media - Brain Heart Infusion. Incubation was performed in blood agar and McConkey agar at 37 degree Celsius for 48 hours. The incubated samples were then evaluated for the presence of microorganism by standard microbiological procedures and the organism was identified. If there were no organisms grown, the samples were kept incubated and evaluated for the presence of organism after 72hours. The flora grown from routine sampling of operation theatres were Staphylococcus aureus and Bacillus species being the commonest, followed by coagulase negative Staphylococcus species and non-fermenters of gram negative bacilli respectively.
Results
Out of one hundred, 3 samples were lost while transferring from OT complex to microbiology laboratory. Final analysis included 97 samples. Statistical analysis was performed using Paired t test for categorical variables and non categorical by Levene test and Pearson correlation. No correlation was found either between openings of the propofol vial and inoculation time (Table 1 & Table 3, Graph 1) or between differences of the temperature and bacterial isolation (Table 2). Total of 41 samples among 97 studied showed bacterial growth (42.26%). In propofol vials without edetate, organisms were grown in 43.75% (7 samples in 16) whereas in propofol vials with edetate, incidence was 41.97% (34 samples in 81) (Table 4). However the difference in incidence between the samples with and without edetate was not statistically significant (p value>0.005) One sample without edetate grew two species of bacteria, Staphylococcus and Bacillus species. Most common organism was Staphylococcus aureus (70%), followed by Enterococcus (12%), Acinetobacter (7%) and Bacillus species, Pseudomonas and Staphylococcus citreus (Table 4).

- Correlation between opening time and inoculation time
| Opening time | Inoculation time | ||
|---|---|---|---|
| Opening time | Pearson correlation sig. (2-tailed) | 1 | 0.584– 0.000 |
| N | 100 | 100 | |
| Inoculation time | Pearson correlation sig. (2-tailed) | 0.584–0.000 | 1 |
| N | 100 | 100 |
Correlation is significant at the level 0.01 (2- tailed)
| Temperature | Edetate | N | Mean | Standard deviation | Standard error Mean |
|---|---|---|---|---|---|
| Present | 83 | 23.42 | 3.190 | 0.350 | |
| Absent | 17 | 23.12 | 1.409 | 0.342 |
| Difference between the inoculation time and opening time | Edetate | N | Mean | Standard deviation | Standard error Mean |
|---|---|---|---|---|---|
| Present | 83 | 2.6537 | 1.93182 | 0.21204 | |
| Absent | 17 | 2.7518 | 1.35054 | 0.32755 |
| Time of inoculation | Samples with edetate | Samples without edetate | ||||
|---|---|---|---|---|---|---|
| Total | Organism present | Total | Organism | present | ||
| 0 to 30min | 7 | Nil | − | 0 | nil | − |
| 30min to 90min | 25 | 13 | 11- Staph aureus | 4 | 3 | 3-Staph aureus |
| 1-Enterococcus | 1- missing | |||||
| 1-Pseudomonas | ||||||
| 90min to 150min | 15 | 9 | 2-Enterococcus | 5 | 3 | 1-Enterococcus |
| 1-Bacillus sp | 1-Staph aureus | |||||
| 1-Staph aureus | 1-Staph aureus and Bacillus species | |||||
| 1- Staph citreus | ||||||
| 1-Acinetobacter | ||||||
| 150min to 270min | 20 | 6 | 5-Staph aureus | 6 | 1 | |
| 1-Acinetobacter | ||||||
| 1-missing | ||||||
| 1-Staph aureus | ||||||
| 270min to 390min | 16 | 6 | 4-staph aureus | 2 | nil | |
| 1-Acinetobacter | ||||||
| 1-Enterococcus | ||||||
| 1- missing | ||||||
| Levene’s test of equality of variances | t-test for equality of means | |||||
|---|---|---|---|---|---|---|
| f | Sig. | t | df | Sig. | ||
| Temperature | Equal variances assumed | 4.755 | 0.032 | 0.384 | 98 | 0.702 |
| Equal variances not assumed | 0.621 | 55.322 | 0.537 | |||
| t-test for equality of means | |||||
|---|---|---|---|---|---|
| Mean difference | Standard error difference | 95% confidence interval of the difference | |||
| lower | upper | ||||
| Temperature | Equal variances assumed | 0.304 | 0.791 | −1.266 | 1.875 |
| Equal variances not assumed | 0.304 | 0.489 | −0.676 | 1.284 | |
| Levene’s test of equality of variances | t-test for equality of means | |||||
|---|---|---|---|---|---|---|
| f | Sig. | t | df | Sig. (2-tailed) | ||
| Difference between the inoculation time and opening time | Equal variances assumed | 6.661 | 0.011 | −0.199 | 98 | 0.843 |
| Equal variances not assumed | −0.251 | 31.153 | 0.803 | |||
| t-test for equality of means | |||||
|---|---|---|---|---|---|
| Mean difference | Standard error difference | 95% confidence interval of the difference | |||
| lower | upper | ||||
| Difference between the inoculation time and opening time | Equal variances assumed | −0.09803 | 0.49235 | −1.07509 | 0.87903 |
| Equal variances Not assumed | −0.09803 | 0.39020 | −0.89369 | 0.69763 | |
| Samples | |||||
|---|---|---|---|---|---|
| valid | missing | Total | |||
| N | Percentage | N | Percentage | N | Percentage |
| 97 | 97% | 3 | 3% | 100 | 100% |
| Organism | Total | |||
|---|---|---|---|---|
| Present | Absent | |||
| Edetate | Present | 34 | 47 | 81 |
| Absent | 7 | 9 | 16 | |
| Total | 41 | 56 | 97 | |
Discussion
The day-to-day practicalities of clinical anaesthesia dictate that some delay between the opening of propofol and its injection into the patient is unavoidable. Further, these delays are variable in both duration and causation. Our study compared the incidence of bacterial growth in propofol vials from immediately after opening of the vial up to 390 minutes after opening the vial. Bacterial contamination was observed in 42.26% of samples, significantly more compared to other studies which reported incidence rates ranging from 6.3% to 26%. One of the reasons for lower incidence rates in the previous studies were due to immediate inoculation after opening the vial with the maximum time being up to 90 minutes5. However, even in our study, there was no statistically significant difference in incidence of bacterial growth with different time intervals of opening and inoculation. This finding is consistent with those of previous studies5.
Type of bacteria
Overall, Staphylococcus aureus (70%) was the most common organism, followed by Enterococcus (12%), Acinetobacter (7%) and Bacillus species, Pseudomonas and Staphylococcus citrius in our study. Previous studies5 have also shown Staphylococcus species was the commonest isolated organism followed by Diphteroids, Micrococcus and Bacillus species. One sample had grown two species of bacteria, Staphylococcus and Bacillus species.
Staphylococcus aureus is both a commensal organism and a pathogen. The anterior nares are the main ecological niche for S. aureus6. Approximately 20% of individuals are persistently nasally colonized with S. aureus, and 30% are intermittently colonized. However, other sites may be colonized, including the axillae, groin, and gastrointestinal tract. Colonization provides a reservoir from which bacteria can be introduced when host defences are breached, whether by shaving, aspiration, insertion of an indwelling catheter, or surgery. Colonization clearly increases the risk for subsequent infection6, 7, 8.
Bacillus species are common contaminating organisms of addicts' heroin and injection paraphernalia, due to their ubiquity in natural, domestic and hospital environments and their production of resistant endospores9. Reports of “pseudo-outbreaks” of Bacillus species is connected with contaminated clinical and laboratory equipment9.
One study1 isolated Moraxella osloensis, Enterobacter agglomerans and Serratia marcescens from opened propofol vials. Studies have shown that propofol supports the growth of Staphylococcus species10, 11, Candida albicans10, 11, Moraxella osloensis10 and Pseudomonas aeruginosa11. Another study12 showed that propofol strongly supports the growth of E. coli and C. albicans but is bacteriostatic toward S. aureus and weakly bactericidal toward P. aeruginosa.
Staphylococcus aureus, epidermidis, diphteroids were the bacterial strains isolated from propofol by preparation technique similar to the clinical practice in a study13.
Enterococci are a part of the normal human faecal flora. Sites less often colonized are the oral cavity, genitourinary tract and skin especially in the perineal area. The main sites of colonization in the hospitalized patients are soft tissue wounds, ulcers and the gastrointestinal tract (GIT)14. Enterococci have emerged as an important cause of nosocomial infections. These infections are recognized by 3 ts - tough, tenacious and often troublesome14, 15. The most frequent infections caused by enterococci are urinary tract infections 14, 16. The second most frequent enterococcal infections are intra - abdominal and intra - pelvic abscesses or post-surgery wound infections14, 16. The third most frequent infection caused by these organisms is blood stream infections14, 17. Other infections caused with lower frequency are central nervous system (CNS) and neonatal infections. Enterococci rarely cause respiratory tract infections, osteomyelitis, or cellulitis14, 18.
The gram-negative coccobacillus, Acinetobacter, a pathogen once seen only in hot, humid climates, has become an increasingly common nosocomial problem even in temperate climates19. The association of A.baumannii with pneumonia, bacteremia, wound infections, urinary tract infections, and meningitis has been well described 20, 21. Risk factors associated with colonization or infection (which can be difficult to distinguish) include prolonged hospitalization, intensive care unit admission, recent surgical procedures, antimicrobial agent exposure, central venous catheter use, prior hospitalization, nursing home residence, and local colonization pressure on susceptible patients 20, 21.
The prevalence of colonisation by P. aeruginosa in healthy subjects is usually low, but higher colonisation rates can be encountered following hospitalisation, especially amongst subjects treated with broad-spectrum antimicrobial agents. Colonisation is common in the respiratory tract of mechanically ventilated patients, in the gastrointestinal tract of patients receiving anticancer chemotherapy, and on the skin of burn patients22. Also, sinks, mops, disinfectant solutions, respiratory equipment, food mixers and other moist environments can act as reservoirs of P. aeruginosa in the hospital setting22, 23, 23.
Staphylococcus citreus occurs as the normal flora of nose in upto 1% and normal flora of throat in 15 - 25%25.
The difference in type of bacteria compared to previous studies1, 5, 13 could be explained by geographical differences and local practices between the present and previous study locations.
Effect of edetate
Our study did not show statistically significant difference in incidence (p value=1) between bacterial growth in propofol vials with and without edetate. With absence of edetate vials organism were found in 43.75% versus 41.97%. Sticking to propofol handling guidelines26 including hand wash may help in decreasing the incidence of bacterial growth in propofol vials. Edetate has proven to have inhibitory effect on bacterial growth27. Our study could not establish statistically significant difference in incidence of bacterial growth at different temperatures. Further studies are required to evaluate the effect of temperature on bacterial growth.
Conclusion
Propofol being lipid emulsion facilitates bacterial growth and edetate, though has inhibitory effects, do not completely prevent bacterial growth. Hence strict aseptic precautions including hand wash and safe injection practices for administration of propofol have to be followed. The gap between what is recommended and what is actually done clinically regarding safe injection practices should be identified and rectified.
References
- Postoperative infections traced to contamination of an intravenous anesthetic, propofol. New England Journal of Medicine.. 1995;333:147-54.
- [Google Scholar]
- The effect of lidocaine on bacterial growth in propofol. Anesth Analg. 1999;88:936-8.
- [Google Scholar]
- Postsurgical infections associated with an extrinsically contaminated intravenous anesthetic agent California, Illinois, Maine, and Michigan, 1990. MMWR Morb Mortal Wkly Rep. 1990;39:426-7. 433
- [Google Scholar]
- Staphylococcus aureus bloodstream infections among patients undergoing electroconvulsive therapy traced to breaks in infection control and possible extrinsic contamination by propofol. Anesth Analg. 1997;85:420.:5.
- [Google Scholar]
- Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clinical infectious diseases. 2008;46((Supplement 5)):S350-9.
- [Google Scholar]
- The role of nasal carriage in Staphylococcus aureus infections. The Lancet infectious diseases.. 2005;5:751-62.
- [Google Scholar]
- Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clinical microbiology reviews.. 1997;10:505-20.
- [Google Scholar]
- Bacillus species of medical and veterinary importance. Journal of medical microbiology. 1988;25:157-65.
- [Google Scholar]
- Growth curves of Staphylococcus aureus, Candida albicans and Moraxella osloensis in propofol and other media. Canadian journal of anaesthesia.. 1992;39:509-11.
- [Google Scholar]
- Growth of micro-organisms in solutions of intravenous anaesthetic agents. Anaesthesia. 1993;48:30-2.
- [Google Scholar]
- Growth of microorganisms in propofol, thiopental, and a 1: 1 mixture of propofol and thiopental. Anesthesia & Analgesia.. 1996;82:475-8.
- [Google Scholar]
- Enterococcal infections & antimicrobial resistance. Indian J Med Res.. 2008;128:111-21.
- [Google Scholar]
- Enterococci attract attention of concerned microbiologists. ASM News. 2000;66:540-5.
- [Google Scholar]
- Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001;32((Supply 2)):S133-45.
- [Google Scholar]
- Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991;91:72S-75S.
- [Google Scholar]
- Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clinical infectious diseases. 2008;46:1254-63.
- [Google Scholar]
- Treatment of Acinetobacter infections. Clinical infectious diseases. 2010;51:79-84.
- [Google Scholar]
- Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clinical Microbiology and Infection.. 2005;11((s4)):17-32.
- [Google Scholar]
- Epidemiology of infections due to Pseudomonas aeruginosa. Review of Infectious Diseases. 1984;6((Supplement 3)):S627-42.
- [Google Scholar]
- Pseudomonas aeruginosa. Principles and practice of infectious diseases. 2000;5:1980-2003.
- [Google Scholar]
- Studies in the common cold: I. Observations of the normal bacterial flora of nose and throat with variations occurring during colds. The Journal of Experimental Medicine.. 1926;43((3)):415.
- [Google Scholar]
- Safe injection practices for administration of propofol. AORN journal.. 2012;95:365-72.
- [Google Scholar]
- Microbial growth in propofol formulations with disodium edetate and the influence of venous access system dead space*. Anaesthesia.. 2007;62:575-80.
- [Google Scholar]
